The present invention includes novel recombinant canine herpes virus (CHV) and
novel recombinant CHV genomes, and particularly to those CHV and CHV genomes that
contain heterologous nucleic acid molecules. The present invention also relates
to the use of such genomes and viruses in a variety of applications, including
as therapeutic compositions to protect animals from disease. The present invention
also relates to novel isolated CHV nucleic acid molecules, to CHV proteins encoded
by such nucleic acid molecules, and to antibodies raised against such CHV proteins
as well as to the use of such CHV nucleic acid molecules, proteins and antibodies
as therapeutic compositions to protect an animal from CHV. The present invention
also includes constructs comprising CHV nucleic acid molecules that include heterologous
nucleic acid molecules, to recombinant vectors including such constructs, and to
the use of such constructs and vectors in the production of recombinant CHV and
recombinant CHV genomes.